Cargando…
Commentary: The Clinical Impact of the C(0)/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients
Autores principales: | Thölking, Gerold, Reuter, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938239/ https://www.ncbi.nlm.nih.gov/pubmed/33692688 http://dx.doi.org/10.3389/fphar.2021.603345 |
Ejemplares similares
-
The Clinical Impact of the C(0)/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients
por: van Gelder, Teun, et al.
Publicado: (2020) -
The Tacrolimus Metabolism Rate and Dyslipidemia after Kidney Transplantation
por: Thölking, Gerold, et al.
Publicado: (2021) -
Fast Tacrolimus Metabolism Does Not Promote Post-Transplant Diabetes Mellitus after Kidney Transplantation
por: Jehn, Ulrich, et al.
Publicado: (2022) -
Influence of tacrolimus metabolism rate on renal function after solid organ transplantation
por: Thölking, Gerold, et al.
Publicado: (2017) -
The Tacrolimus Metabolism Rate Influences Renal Function after Kidney Transplantation
por: Thölking, Gerold, et al.
Publicado: (2014)